KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Free Cash Flow (2016 - 2025)

Sarepta Therapeutics has reported Free Cash Flow over the past 15 years, most recently at $127.6 million for Q4 2025.

  • Quarterly results put Free Cash Flow at $127.6 million for Q4 2025, up 136.48% from a year ago — trailing twelve months through Dec 2025 was -$307.5 million (up 10.3% YoY), and the annual figure for FY2025 was -$307.5 million, up 10.3%.
  • Free Cash Flow for Q4 2025 was $127.6 million at Sarepta Therapeutics, up from -$37.5 million in the prior quarter.
  • Over the last five years, Free Cash Flow for SRPT hit a ceiling of $229.5 million in Q2 2025 and a floor of -$627.1 million in Q1 2025.
  • Median Free Cash Flow over the past 5 years was -$103.5 million (2022), compared with a mean of -$103.3 million.
  • Biggest five-year swings in Free Cash Flow: crashed 218.27% in 2022 and later skyrocketed 1713.64% in 2025.
  • Sarepta Therapeutics' Free Cash Flow stood at -$31.5 million in 2021, then crashed by 218.27% to -$100.4 million in 2022, then grew by 26.57% to -$73.7 million in 2023, then soared by 173.23% to $54.0 million in 2024, then surged by 136.48% to $127.6 million in 2025.
  • The last three reported values for Free Cash Flow were $127.6 million (Q4 2025), -$37.5 million (Q3 2025), and $229.5 million (Q2 2025) per Business Quant data.